Escient Pharmaceuticals, Inc

This study tested whether an experimental drug called EP262 could reduce symptoms in people with chronic spontaneous urticaria (long-lasting hives with no clear trigger). 113 participants who still had significant hives despite standard antihistamine treatment were randomly assig…